U.S. STOCKS ON THE MOVE-United Technologies, P&G, IBM, Synchrony
The Day Ahead newsletter:
The Morning News Call newsletter:
U.S. stocks were set to open higher on Wednesday, with strong earnings from Dow components IBM, United Technologies and Procter & Gamble looking to propel a rebound after Wall Street suffered its second biggest decline in 2019.
At 9:14 ET, Dow e-minis were up 0.78 percent at 24,580. S&P 500 e-minis were up 0.50 percent at 2,645.25, while Nasdaq 100 e-minis were up 0.54 percent at 6,689.25.
The top three NYSE percentage gainers premarket:
** Synchrony Financial, up 12.3 pct
** Portland General Electric Co, up 10.1 pct
** Restaurant Brands International Inc, up 8.8 pct
The top three NYSE percentage losers premarket:
** Trinseo Sa, down 12.3 pct
** Bellatrix Exploration Ltd, down 8.8 pct
** Quotient Technology Inc, down 9.4 pct
The top three Nasdaq percentage gainers premarket:
** Auris Medical Holding, up 31.9 pct
** Soligenix Inc, up 30.1 pct
** Athersys Inc, up 20.1 pct
The top three Nasdaq percentage losers premarket:
** Bellerophon Therapeutics Inc, down 25.9 pct
** Selecta Biosciences Inc, down 23.7 pct
** Avalon Globocare Corp, down 23.5 pct
** United Technologies Corp: up 4.9 pct premarket
United Technologies Corp: Shares rise on Q4 profit beat
United Tech profit beats on higher aero parts sales
** Procter & Gamble Co: up 4.4 pct premarket
Procter & Gamble: Up as Q2 results beat
P&G raises forecast on strength of skin care, detergent brands
** Comcast Corp: up 2.9 pct premarket
Comcast Corp: Set to jump as Q4 revenue beats analyst expectations
Comcast results beat on lower-than-expected video losses
** Rollins Inc: down 4.9 pct premarket
Rollins Inc: Drops after Q4 EPS and revenue miss
** PTC Therapeutics: down 8.9 pct premarket
PTC Therapeutics: Slides on $200 mln stock offering plan
** Restaurant Brands: up 8.8 pct premarket
Restaurant Brands: Rises after naming Burger King chief Jose Cil as CEO
Restaurant Brands names Burger King boss Jose Cil as CEO
** Bellerophon Therapeutics Inc: down 25.9 pct premarket
Small drugmakers Bellerophon and Rexahn slide on stock deal plans
** IBM Corp: up 7.2 pct premarket
IBM: Gains on strong 2019 profit forecast
** Merck & Co: down 0.3 pct premarket
Merck needs more aggressive business development - BMO Capital Markets
** Tesla Inc: down 2.2 pct premarket
Tesla: 'Dream deferred,' sell the 'Elon premium' - RBC
** Walmart Inc: up 1.4 pct premarket
MS cautious of hard goods retailers, ups Walmart to 'outperform'
** Teva Pharmaceuticals Industries Ltd: up 2.9 pct premarket
Teva: Rises after UBS says stock "too cheap to ignore", upgrades
** Synchrony Financial: up 12.3 pct premarket
Synchrony Financial: Rises after Walmart drops lawsuit, strong Q4 results
** Kimberly-Clark Corp: down 3.7 pct premarket
Kimberly-Clark: Drops on weak 2019 profit forecast
Kimberly-Clark misses profit estimates, shares fall
** Abbott Laboratories: down 2.4 pct premarket
Abbott Labs: Falls on Q4 revenue miss; weak Q1 profit forecast
** Athersys Inc: up 20.1 pct premarket
Athersys: Surges on positive lung disease treatment results
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.